FDA
approval
· 2016-05-05
FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
Summary
The FDA approved a supplemental application for benazepril hydrochloride and hydrochlorothiazide (an antihypertensive combination) submitted by Padagis US LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE)